Abstract:One of the major applications of generative models for drug discovery targets the lead-optimization phase. During the optimization of a lead series, it is common to have scaffold constraints imposed on the structure of the molecules designed. Without enforcing such constraints, the probability of generating molecules with the required scaffold is extremely low and hinders the practicality of generative models for de novo drug design. To tackle this issue, we introduce a new algorithm, named SAMOA (Scaffold Constrained Molecular Generation), to perform scaffold-constrained in silico molecular design. We build on the well-known SMILES-based Recurrent Neural Network (RNN) generative model, with a modified sampling procedure to achieve scaffold-constrained generation. We directly benefit from the associated reinforcement learning methods, allowing to design molecules optimized for different properties while exploring only the relevant chemical space. We showcase the method's ability to perform scaffold-constrained generation on various tasks: designing novel molecules around scaffolds extracted from SureChEMBL chemical series, generating novel active molecules on the Dopamine Receptor D2 (DRD2) target, and finally, designing predicted actives on the MMP-12 series, an industrial lead-optimization project.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jcim.0c01015?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.0c01015</a>.Availability of data used to train models and run experiments, algorithmic description of naive policy masking (Algorithm S1), algorithmic description of hill-climbing (Algorithm S2), examples of molecules obtained after sampling the core of fexofenadine (Figure S1 for sampled molecules, Figure S2 for the original molecule), examples of molecules obtained after replacing the ring system of fexofenadine (Figure S3), distributions of ClogP, Molecular Weight, QED and SAS for reference molecules, molecules where a branched decoration was sampled, and molecules where the core was sampled (Figure S4), the 17 validation scaffolds from SureChEMBL (Figure S5), histograms of Tanimoto similarities between generated molecules for each of the DRD2 scaffolds (Figure S6), and unicity of sampled decorations for each open positions of the DRD2 scaffolds (Figure S7) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.0c01015/suppl_file/ci0c01015_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Development of a Method To Consistently Quantify the Structural Distance between Scaffolds and To Assess Scaffold Hopping Potential

Computational Methods for Scaffold Hopping

On Scaffolds and Hopping in Medicinal Chemistry

“Molecular Anatomy”: a new multi-dimensional hierarchical scaffold analysis tool

Molecular Scaffold Hopping via Holistic Molecular Representation

Scaffold-Hopped Compound Identification by Ligand-Based Approaches with a Prospective Affinity Test

Computational Bioactivity Fingerprint Similarities To Navigate the Discovery of Novel Scaffolds

A scaffold‐based deep generative model considering molecular stereochemical information

DiffHopp: A Graph Diffusion Model for Novel Drug Design via Scaffold Hopping

TurboHopp: Accelerated Molecule Scaffold Hopping with Consistency Models

Scaffold-Induced Molecular Graph (SIMG): Effective Graph Sampling Methods for High-Throughput Computational Drug Discovery

A molecular representation to identify isofunctional molecules

Assessing the Scaffold Diversity of Screening Libraries

Free energy perturbation (FEP)-guided scaffold hopping

AIScaffold: A Web-Based Tool for Scaffold Diversification Using Deep Learning

RegScaf: a regression approach to scaffolding

Scaffold-Constrained Molecular Generation

3D-Scaffold: A Deep Learning Framework to Generate 3D Coordinates of Drug-like Molecules with Desired Scaffolds

Unraveling Low-Resolution Structural Data Of Large Biomolecules By Constructing Atomic Models With Experiment-Targeted Parallel Cascade Selection Simulations

Learning to Extend Molecular Scaffolds with Structural Motifs

Scaffold hopping approaches for dual-target antitumor drug discovery: opportunities and challenges